Evidence map›Paper›PMID 39323779›Full record

ArticleHeliyon2024

Single-cell mapping of peripheral blood mononuclear cells reveals key transcriptomic changes favoring coronary artery lesion in IVIG-resistant Kawasaki disease.

Yuanzheng Zheng, Yan Zhou, Di Zhu, Xing Fu, Cao Xie, Shuna Sun, Guoyou Qin, Mei Feng, Chenglong Liu, Qingtong Zhou and 6 more

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. CD14Frontiers in immunology · 2025
    Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The role of SLC22A4 in Acute Myeloid Leukaemia.Mediterranean journal of hematology and infectious diseases · 2025
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yuanzheng ZhengChildren's Hospital of Fudan University, National Children's Medical Center, Shanghai, 201102, China.
Yan ZhouThe National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Di ZhuDepartment of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Xing FuAccuramed Technology (Shanghai) Ltd., Shanghai, 200233, China.
Cao XieSchool of Pharmacy, Fudan University, Shanghai, 201203, China.
Shuna SunChildren's Hospital of Fudan University, National Children's Medical Center, Shanghai, 201102, China.
Guoyou QinSchool of Public Health, Fudan University, Shanghai, 200032, China.
Mei FengDepartment of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Chenglong LiuDepartment of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Qingtong ZhouDepartment of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Fang LiuChildren's Hospital of Fudan University, National Children's Medical Center, Shanghai, 201102, China.
Chen ChuChildren's Hospital of Fudan University, National Children's Medical Center, Shanghai, 201102, China.
Feng WangChildren's Hospital of Fudan University, National Children's Medical Center, Shanghai, 201102, China.
Dehua YangThe National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Ming-Wei WangDepartment of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
Yonghao GuiChildren's Hospital of Fudan University, National Children's Medical Center, Shanghai, 201102, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) poses a considerable challenge to patients and their families due to its severe complications. Previous researches have highlighted the critical role of immune disorders in its pathogenesis. However, fragmented studies based on isolated cases hinder a comprehensive understanding of this deadly illness. This study aimed to explore the overall landscape of peripheral blood mononuclear cells (PBMCs) in IVIG-resistant KD patients using single-cell RNA sequencing (scRNA-seq). Methods: The scRNA-seq was used to characterize the transcriptomic profiles of IVIG-resistant KD patients, IVIG-responsive KD patients, and healthy controls. Data quality control (QC) and subsequent analysis were conducted using various R packages. These included DoubletFinder and Harmony for QC, Seurat and SingleR for identifying and annotating major cell types, ggpubr for calculating and visualizing the percentages of each cell type, Seurat for characterizing differentially expressed genes (DEGs) between groups, pheatmap for visualizing the DEGs, clusterProfiler for performing Gene Ontology (GO) enrichment analysis of DEGs, scRepertoire for TCR and BCR data analysis, Monocle for assessing cell differentiation trajectories, and CellChat for intercellular interaction evaluation. Results: High-quality single-cell transcriptome data from 12 participants were analyzed, including five with IVIG-resistant KD, four with IVIG-responsive KD, and three healthy controls. We identified 10 major cell types and observed that the differentiation of CD8 Conclusion: Complex immunopathological changes occur during the development of CAL in IVIG-resistant KD. Stunted differentiation of CD8

Indexed as

Coronary artery lesionIVIG-ResistantKawasaki diseaseSingle cell RNA-Sequencing

Identifiers

PMID39323779
PMCPMC11422586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.